|
EP2934532B1
(en)
|
2012-12-20 |
2019-10-23 |
Purdue Research Foundation |
Chimeric antigen receptor-expressing t cells as anti-cancer therapeutics
|
|
GB201418965D0
(enExample)
|
2014-10-24 |
2014-12-10 |
Ospedale San Raffaele And Fond Telethon |
|
|
US20170151281A1
(en)
|
2015-02-19 |
2017-06-01 |
Batu Biologics, Inc. |
Chimeric antigen receptor dendritic cell (car-dc) for treatment of cancer
|
|
SG10201913151TA
(en)
|
2015-09-09 |
2020-03-30 |
Seattle Childrens Hospital Dba Seattle Childrens Res Inst |
Genetic engineering of macrophages for immunotherapy
|
|
IL260987B2
(en)
|
2016-02-04 |
2024-09-01 |
Zhenglun Zhu |
Treatment and diagnosis of inflammatory disorders
|
|
DK3432912T5
(da)
|
2016-03-25 |
2024-09-16 |
Periphagen Inc |
Hsv-vektorer med høj transduktion
|
|
CA3019835A1
(en)
|
2016-04-08 |
2017-10-12 |
Purdue Research Foundation |
Methods and compositions for car t cell therapy
|
|
CN110582288B
(zh)
|
2017-02-28 |
2024-09-20 |
恩多塞特公司 |
用于car t细胞疗法的组合物和方法
|
|
WO2018183447A1
(en)
*
|
2017-03-28 |
2018-10-04 |
Zhenglun Zhu |
Methods of treating neoplastic diseases
|
|
KR20190141695A
(ko)
*
|
2017-04-13 |
2019-12-24 |
센티 바이오사이언시스, 인코포레이티드 |
병용 암 면역요법
|
|
CA3063695A1
(en)
*
|
2017-05-17 |
2018-11-22 |
Seattle Children's Hospital (Dba Seattle Children's Research Institute |
Generating mammalian t cell activation inducible synthetic promoters (syn+pro) to improve t cell therapy
|
|
WO2019014398A1
(en)
|
2017-07-11 |
2019-01-17 |
Actym Therapeutics, Inc. |
MODIFIED IMMUNOSTIMULATORY BACTERIAL STRAINS AND USES THEREOF
|
|
CA3081456A1
(en)
*
|
2017-11-01 |
2019-05-09 |
Editas Medicine, Inc. |
Methods, compositions and components for crispr-cas9 editing of tgfbr2 in t cells for immunotherapy
|
|
CA3082611A1
(en)
*
|
2017-11-17 |
2019-05-23 |
Memorial Sloan-Kettering Cancer Center |
Methods and compositions for alleviating cytokine release syndrome
|
|
WO2019144095A1
(en)
|
2018-01-22 |
2019-07-25 |
Seattle Children's Hospital (dba Seattle Children's Research Institute) |
Methods of use for car t cells
|
|
JP7568224B2
(ja)
|
2018-02-23 |
2024-10-16 |
エンドサイト・インコーポレイテッド |
Ｃａｒ ｔ細胞療法のための配列決定法
|
|
DE102018108612A1
(de)
|
2018-03-21 |
2019-09-26 |
Immatics US, Inc. |
Verfahren zur erhöhung der persistenz von adoptiv infundierten t-zellen
|
|
US11267866B2
(en)
|
2018-04-04 |
2022-03-08 |
Nant Holdings Ip, Llc |
Immunoglobulin complex comprising interleukin-15
|
|
CN119656304A
(zh)
*
|
2018-04-12 |
2025-03-21 |
凯德药业股份有限公司 |
使用肿瘤微环境的特征的嵌合受体t细胞治疗
|
|
CN108727504B
(zh)
*
|
2018-04-16 |
2021-08-27 |
泉州向日葵生物科技有限公司 |
一种ifn与抗pd-l1抗体的融合蛋白及其应用
|
|
US10869888B2
(en)
|
2018-04-17 |
2020-12-22 |
Innovative Cellular Therapeutics CO., LTD. |
Modified cell expansion and uses thereof
|
|
AU2019255789B2
(en)
|
2018-04-19 |
2025-11-20 |
The Regents Of The University Of California |
Compositions and methods for gene editing
|
|
CA3099265A1
(en)
|
2018-05-07 |
2019-11-14 |
Bellicum Pharmaceuticals, Inc. |
Natural killer cell products and methods
|
|
US12527821B2
(en)
|
2018-05-15 |
2026-01-20 |
The Brigham And Women's Hospital, Inc. |
Compositions and methods related to tumor cell killers and vaccines
|
|
WO2019246261A1
(en)
*
|
2018-06-19 |
2019-12-26 |
Regents Of The University Of Minnesota |
Genome engineering primary monocytes
|
|
CA3176812A1
(en)
|
2018-07-11 |
2020-01-16 |
Actym Therapeutics, Inc. |
Engineered immunostimulatory bacterial strains and uses thereof
|
|
CN108823171A
(zh)
*
|
2018-07-24 |
2018-11-16 |
武汉赛云博生物科技有限公司 |
一种基因工程细胞及体外高效扩增nk细胞的方法
|
|
US12240915B2
(en)
|
2018-08-30 |
2025-03-04 |
Innovative Cellular Therapeutics Holdings, Ltd. |
Chimeric antigen receptor cells for treating solid tumor
|
|
EP3876977A1
(en)
|
2018-11-06 |
2021-09-15 |
The Regents Of The University Of California |
Chimeric antigen receptors for phagocytosis
|
|
GB201818110D0
(en)
*
|
2018-11-06 |
2018-12-19 |
Macrophox Ltd |
Monocytes for cancer targeting
|
|
US20220000921A1
(en)
*
|
2018-11-20 |
2022-01-06 |
Innovative Cellular Therapeutics Holdings, Ltd. |
Modified Cell Expressing Therapeutic Agent and Uses thereof
|
|
CN113226336B
(zh)
*
|
2018-12-17 |
2024-03-15 |
苏州克睿基因生物科技有限公司 |
一种在细胞中递送基因的方法
|
|
WO2020160217A1
(en)
*
|
2019-02-01 |
2020-08-06 |
Seattle Children's Hospital (dba Seattle Children's Research Institute) |
Microenvironment sensors to regulate engineered gene expression
|
|
KR20220004959A
(ko)
|
2019-02-27 |
2022-01-12 |
액팀 테라퓨틱스, 인코퍼레이티드 |
종양, 종양-상주 면역 세포, 및 종양 미세환경을 콜로니화하기 위해 조작된 면역자극성 박테리아
|
|
JP2022531814A
(ja)
*
|
2019-03-12 |
2022-07-12 |
イノベイティブ セルラー セラピューティクス ホールディングス，エルティディ |
改変細胞の増幅およびその応用
|
|
CA3135165A1
(en)
*
|
2019-03-28 |
2020-10-01 |
Sierra Oncology, Inc. |
Methods of treating cancer with chk1 inhibitors
|
|
US11026973B2
(en)
|
2019-04-30 |
2021-06-08 |
Myeloid Therapeutics, Inc. |
Engineered phagocytic receptor compositions and methods of use thereof
|
|
CN110760480B
(zh)
*
|
2019-07-09 |
2021-07-02 |
杭州师范大学 |
一种抗肿瘤nk细胞及其制备方法
|
|
US12702708B2
(en)
|
2019-08-21 |
2026-08-11 |
Innovative Cellular Therapeutics Holdings, Ltd. |
Presenting cell and use thereof in cell therapy
|
|
WO2021046243A2
(en)
|
2019-09-03 |
2021-03-11 |
Myeloid Therapeutics, Inc. |
Methods and compositions for genomic integration
|
|
WO2021050752A1
(en)
*
|
2019-09-11 |
2021-03-18 |
The Board Of Trustees Of The Leland Stanford Junior University |
Chimeric orthogonal receptor proteins and methods of use
|
|
BR112022005044A2
(pt)
*
|
2019-09-17 |
2022-07-05 |
Ohio State Innovation Foundation |
Peptídeo quimérico, peptídeo sintético, composição farmacêutica, anticorpo, método de tratamento
|
|
WO2021064655A1
(en)
*
|
2019-10-02 |
2021-04-08 |
Massachusetts Institute Of Technology |
High-throughput genetic screening
|
|
US10980836B1
(en)
|
2019-12-11 |
2021-04-20 |
Myeloid Therapeutics, Inc. |
Therapeutic cell compositions and methods of manufacturing and use thereof
|
|
CN111150748A
(zh)
*
|
2019-12-27 |
2020-05-15 |
杭州荣谷生物科技有限公司 |
重组溶瘤病毒在制备治疗消化道癌药物中的用途
|
|
CN111087460B
(zh)
*
|
2020-01-14 |
2021-07-30 |
中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） |
一种广谱型抗菌肽及其应用
|
|
US12076343B2
(en)
|
2020-02-19 |
2024-09-03 |
Innovative Cellular Therapeutics Holdings, Ltd. |
Engineered safety in cell therapy
|
|
EP4121447A1
(en)
|
2020-03-20 |
2023-01-25 |
Lyell Immunopharma, Inc. |
Novel recombinant cell surface markers
|
|
CN120441567A
(zh)
|
2020-04-07 |
2025-08-08 |
Crt先锋基金有限公司 |
Chk1抑制剂的合成方法
|
|
GB202007906D0
(en)
|
2020-05-27 |
2020-07-08 |
Univ Edinburgh |
Method of transfecting macrophages
|
|
US12043654B2
(en)
|
2020-06-02 |
2024-07-23 |
Innovative Cellular Therapeutics Holdings, Ltd. |
Anti-GCC antibody and CAR thereof for treating digestive system cancer
|
|
EP4161536A4
(en)
*
|
2020-06-04 |
2024-08-14 |
Carisma Therapeutics Inc. |
Novel constructs for chimeric antigen receptors
|
|
WO2021259237A1
(en)
*
|
2020-06-22 |
2021-12-30 |
Nanjing Legend Biotech Co., Ltd. |
GENETIC ENGINEERING OF γδ T CELLS FOR IMMUNOTHERAPY
|
|
EP4240367A4
(en)
|
2020-11-04 |
2024-10-16 |
Myeloid Therapeutics, Inc. |
MODIFIED CHIMERIC FUSION PROTEIN COMPOSITIONS AND METHODS OF USE THEREOF
|
|
CA3206549A1
(en)
*
|
2021-01-29 |
2022-08-04 |
Frederick G. Vogt |
Methods of making modified tumor infiltrating lymphocytes and their use in adoptive cell therapy
|
|
AU2022227686A1
(en)
|
2021-02-25 |
2023-07-27 |
Lyell Immunopharma, Inc. |
Ror1 targeting chimeric antigen receptor
|
|
KR20240013094A
(ko)
|
2021-03-17 |
2024-01-30 |
마이얼로이드 테라퓨틱스, 인크. |
조작된 키메라 융합 단백질 조성물 및 그의 사용 방법
|
|
WO2022241029A1
(en)
|
2021-05-11 |
2022-11-17 |
Myeloid Therapeutics, Inc. |
Methods and compositions for genomic integration
|
|
WO2023280307A1
(en)
*
|
2021-07-09 |
2023-01-12 |
Nanjing Legend Biotech Co., Ltd. |
Mutant il-15 compositions and methods thereof
|
|
WO2023288070A1
(en)
*
|
2021-07-15 |
2023-01-19 |
The Regents Of The University Of California |
Human ipsc-derived macrophage
|
|
KR20230044130A
(ko)
*
|
2021-09-24 |
2023-04-03 |
바이오엔시스템스 주식회사 |
Pd-1 및 il-21을 포함하는 융합단백질 이량체 및 이의 용도
|
|
WO2023053828A1
(ja)
*
|
2021-09-30 |
2023-04-06 |
テルモ株式会社 |
化学療法制御装置、化学療法制御システム、化学療法制御装置の制御方法及び化学療法制御プログラム
|
|
US20250000974A1
(en)
*
|
2021-10-27 |
2025-01-02 |
The Regents Of The University Of California |
Combination of human natural killer cells and macrophages for cancer therapy
|
|
CN116463381A
(zh)
*
|
2021-11-19 |
2023-07-21 |
鲲石生物科技(深圳)有限公司 |
一种病毒表达载体及其制备方法和应用
|
|
CN114404600B
(zh)
*
|
2022-01-21 |
2023-06-27 |
首都医科大学附属北京同仁医院 |
一种用于治疗肿瘤的药物组合及其应用
|
|
CN114657143B
(zh)
*
|
2022-03-11 |
2022-10-25 |
西安电子科技大学 |
一种肿瘤微环境调控型car-单核/巨噬细胞及其制备方法和应用
|
|
EP4511049A4
(en)
*
|
2022-04-18 |
2026-04-29 |
Candel Therapeutics Inc |
COMPOSITIONS AND METHODS INTENDED FOR VIRAL VECTORS
|
|
WO2023205657A2
(en)
*
|
2022-04-18 |
2023-10-26 |
City Of Hope |
Compositions for restoring mecp2 gene function and methods of use thereof
|
|
US20260185047A1
(en)
*
|
2022-05-27 |
2026-07-02 |
National Cancer Center |
Production method for proliferative myeloid cells constitutively producing il-12p70
|
|
WO2024215990A2
(en)
*
|
2023-04-13 |
2024-10-17 |
William Marsh Rice University |
Regulated cells expressing cytokines
|
|
WO2025251079A1
(en)
*
|
2024-05-31 |
2025-12-04 |
University Of Massachusetts |
Rna compositions and methods of use thereof in the treatment of cancer
|
|
WO2026062037A1
(en)
|
2024-09-18 |
2026-03-26 |
Myllia Biotechnology Gmbh |
Gene perturbation in human monocyte-derived macrophages
|
|
WO2026069312A1
(en)
|
2024-09-24 |
2026-04-02 |
Yeda Research And Development Co. Ltd. |
Immune cells expressing an inducible therapeutic agent and uses thereof
|
|
CN119020422A
(zh)
*
|
2024-10-28 |
2024-11-26 |
昆明医科大学 |
一种稳转萤火虫萤光素酶靶细胞株的构建方法及其应用
|